Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The financial burden of healthcare-associated infections: a propensity score analysis in an Italian healthcare setting.
Orlando S, Cicala M, De Santo C, Mosconi C, Ciccacci F, Guarente L, Carestia M, Liotta G, Di Giovanni D, Buonomo E, Riccardi F, Palombi L, Emberti Gialloreti L. Orlando S, et al. Among authors: riccardi f. Infect Prev Pract. 2024 Oct 10;7(1):100406. doi: 10.1016/j.infpip.2024.100406. eCollection 2025 Mar. Infect Prev Pract. 2024. PMID: 39758682 Free PMC article.
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patients.
Gravina A, Gargiulo P, De Laurentiis M, Arenare L, De Placido S, Orditura M, Cinieri S, Riccardi F, Ribecco AS, Putzu C, Del Mastro L, Rossi E, Ciardiello F, Di Rella F, Nuzzo F, Pacilio C, Caputo R, Cianniello D, Forestieri V, Giuliano M, Arpino G, Orlando L, Mocerino C, Schettino C, Piccirillo MC, Gallo C, Perrone F. Gravina A, et al. Among authors: riccardi f. ESMO Open. 2025 Jan 3;10(1):104085. doi: 10.1016/j.esmoop.2024.104085. Online ahead of print. ESMO Open. 2025. PMID: 39754976 Free article.
Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer.
Cucciniello L, Blondeaux E, Bighin C, Gasparro S, Russo S, Dri A, Pugliese P, Fontana A, Cortesi E, Ferzi A, Riccardi F, Sini V, Boni L, Fabi A, Montemurro F, De Laurentiis M, Arpino G, Del Mastro L, Gerratana L, Puglisi F. Cucciniello L, et al. Among authors: riccardi f. NPJ Breast Cancer. 2024 Dec 18;10(1):105. doi: 10.1038/s41523-024-00713-8. NPJ Breast Cancer. 2024. PMID: 39695115 Free PMC article.
The journey of patients affected by metastatic hormone receptor-positive/HER2-negative breast cancer from CDK 4/6 inhibitors to second-line treatment: A real-world analysis of 701 patients enrolled in the GIM14/BIOMETA study.
Molinelli C, Bruzzone M, Blondeaux E, Ruelle T, Lanzavecchia C, De Laurentiis M, Russo S, Riccardi F, Sini V, Cognetti F, Arpino G, Fabi A, Pugliese P, Collovà E, Fontana A, Puglisi F, Bighin C, Lambertini M, Del Mastro L. Molinelli C, et al. Among authors: riccardi f. Eur J Cancer. 2024 Dec;213:115113. doi: 10.1016/j.ejca.2024.115113. Epub 2024 Nov 4. Eur J Cancer. 2024. PMID: 39536433 Free article.
Device associated healthcare associated infection (DA-HAI): a detailed analysis of risk factors and outcomes in a university hospital in Rome, Italy.
Guarente L, Mosconi C, Cicala M, De Santo C, Ciccacci F, Carestia M, Emberti Gialloreti L, Palombi L, Quintavalle G, Di Giovanni D, Buonomo E, Moramarco S, Riccardi F, Orlando S. Guarente L, et al. Among authors: riccardi f. Infect Prev Pract. 2024 Aug 18;6(4):100391. doi: 10.1016/j.infpip.2024.100391. eCollection 2024 Dec. Infect Prev Pract. 2024. PMID: 39329082 Free PMC article.
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study.
Arecco L, Latocca MM, Blondeaux E, Riccardi F, Mocerino C, Guarneri V, Mioranza E, Bisagni G, Gasparini E, Puglisi F, Membrino A, Ferro A, Adamo V, Giovanardi F, Tamberi S, Donati S, Landucci E, Biganzoli L, Piccinini S, Pastorino S, de Azambuja E, Poggio F, Lambertini M, Del Mastro L. Arecco L, et al. Among authors: riccardi f. Breast. 2024 Oct;77:103769. doi: 10.1016/j.breast.2024.103769. Epub 2024 Jul 9. Breast. 2024. PMID: 39043079 Free PMC article.
Brazilian Society of Surgical Oncology recommendations on Merkel cell carcinoma surgical treatment.
Lobo MM, Wainstein AJA, Barros AV, Oliveira AF, Jafelicci AS, Molina AS, Bertolli E, Riccardi F, Cavarsan F, Belfort FA, Teixeira FJR, DeBiasi GG, Ribeiro HSC, Almeida HIB, de Oliveira JL, Duprat Neto JP, Rebolho JC, Nunes LF, Junior MJPC, Brandao MA, Brandao PHDM, de Souza RO, Vazquez VL, Pinheiro RN. Lobo MM, et al. Among authors: riccardi f. J Surg Oncol. 2024 Sep;130(4):861-868. doi: 10.1002/jso.27728. Epub 2024 Jun 6. J Surg Oncol. 2024. PMID: 38845222
Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX-Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective-Prospective Study.
Coppola A, Rivolta GF, Quintavalle G, Matichecchia A, Riccardi F, Rossi R, Benegiamo A, Ranalli P, Coluccio V, Tagliaferri A. Coppola A, et al. Among authors: riccardi f. J Clin Med. 2024 Mar 6;13(5):1518. doi: 10.3390/jcm13051518. J Clin Med. 2024. PMID: 38592343 Free PMC article.
239 results